CHF44.10
1.01% today
SIX Swiss Exchange, Nov 27, 04:46 pm CET
ISIN
CH0038389992
Symbol
BION

BB Biotech Stock price

CHF44.55
+3.50 8.53% 1M
+14.95 50.51% 6M
+9.15 25.85% YTD
+7.25 19.44% 1Y
-14.65 24.75% 3Y
-23.85 34.87% 5Y
-14.15 24.11% 10Y
-35.45 44.31% 20Y
SIX Swiss Exchange, Closing price Wed, Nov 26 2025
+0.15 0.34%
ISIN
CH0038389992
Symbol
BION

Key metrics

Basic
Market capitalization
CHF2.4b
Enterprise Value
CHF41.3m
Net debt
positive
Cash
CHF2.3b
Shares outstanding
55.2m
Valuation (TTM | estimate)
P/E
14.8 | 7.5
P/S
4.5 | 8.0
EV/Sales
0.1 | 0.1
EV/FCF
0.1
P/B
1.0
Dividends
DPS
CHF1.80
Yield 1Y | 5Y
4.0% | 4.8%
Growth 1Y | 5Y
-10.0% | -11.9%
Payout 1Y | 3Y
130.4% | -74.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF524.9m | CHF293.5m
EBITDA
- | CHF325.9m
EBIT
CHF496.0m | CHF325.9m
Net Income
CHF166.1m | CHF326.3m
Free Cash Flow
CHF450.5m
Growth (TTM | estimate)
Revenue
93.9% | 161.5%
EBITDA
- | -
EBIT
113.0% | 329.1%
Net Income
32.5% | 329.9%
Free Cash Flow
208.2%
Margin (TTM | estimate)
Gross
99.8%
EBITDA
- | 111.1%
EBIT
94.5%
Net
31.7% | 111.2%
Free Cash Flow
85.8%
Financial Health
Equity Ratio
95.0%
Return on Equity
3.3%
ROCE
21.5%
ROIC
-14,715.2%
Debt/Equity
0.0
More
EPS
CHF3.0
FCF per Share
CHF8.2
Short interest
-
Employees
10
Rev per Employee
CHF11.2m
Show more

Is BB Biotech a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,068 stocks worldwide.

BB Biotech Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BB Biotech forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a BB Biotech forecast:

Buy
90%
Hold
10%

Financial data from BB Biotech

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
525 525
94% 94%
100%
- Direct Costs 0.83 0.83
86% 86%
0%
524 524
98% 98%
100%
- Selling and Administrative Expenses 23 23
17% 17%
4%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 496 496
113% 113%
95%
Net Profit 166 166
32% 32%
32%

In millions CHF.

Don't miss a Thing! We will send you all news about BB Biotech directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BB Biotech Stock News

AD HOC NEWS
about one month ago
Edison issues report on BB Biotech (BION)
AD HOC NEWS
about one month ago
BB BIOTECH AG / CH0038389992
AD HOC NEWS
about one month ago
BB BIOTECH AG / CH0038389992
More BB Biotech News

Company Profile

BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on the development and commercialization of novel drugs sectors. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Head office Switzerland
Employees 10
Founded 1993
Website www.bbbiotech.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today